Medtronic, Inc. Webcast Notice:
Medtronic Vascular Update
Monday, October 17, 2005
12:30 p.m. Eastern Time/11:30 a.m. Central Time
October 10, 2005 -- Medtronic will host an analyst and investor briefing webcast to discuss the results from the ENDEAVOR III clinical trial, during the Transcatheter Cardiovascular Therapeutics (TCT) Conference on Monday, October 17, 2005 in Washington D.C. The briefing will take place after Dr. David Kandzari's formal presentation of the ENDEAVOR III trial results at the TCT's Late-Breaking Clinical Trial Session, Monday, October 17 at 11:00 a.m. EDT. The briefing will include a review of the ENDEAVOR III trial data and the full ENDEAVOR program with remarks from Medtronic senior management.
The webcast is open to the public and will include slides from the TCT presentation. A replay of the webcast also will be available.
To access the webcast, please enter Medtronic's Investor Relations Web site through http://www.medtronic.com/, then follow the link for Investor Relations.
This event is not part of the official TCT Annual Scientific Session.
Contact:
Medtronic, Inc., Minneapolis
Investor Relations:
Jeff Warren, 763-505-2696
or
Public Relations:
Scott Papillon, 707-591-7367
Source: Medtronic, Inc. |
